Investigational Drug Information for Surufatinib
✉ Email this page to a colleague
What is the development status for investigational drug Surufatinib?
Surufatinib is an investigational drug.
There have been 61 clinical trials for Surufatinib.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 7th 2015.
The most common disease conditions in clinical trials are Carcinoma, Neuroendocrine Tumors, and Neoplasms. The leading clinical trial sponsors are Hutchison Medipharma Limited, Sun Yat-sen University, and Fujian Cancer Hospital.
There are two US patents protecting this investigational drug and twenty-one international patents.
Summary for Surufatinib
| US Patents | 2 |
| International Patents | 21 |
| US Patent Applications | 13 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2015-12-07) |
| Vendors | 51 |
Recent Clinical Trials for Surufatinib
| Title | Sponsor | Phase |
|---|---|---|
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer | Fudan University | Phase 1/Phase 2 |
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer | Shanghai Zhongshan Hospital | Phase 1/Phase 2 |
| Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer | Hunan Cancer Hospital | Phase 1/Phase 2 |
Clinical Trial Summary for Surufatinib
Top disease conditions for Surufatinib
Top clinical trial sponsors for Surufatinib
US Patents for Surufatinib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Surufatinib | ⤷ Try a Trial | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Hutchison MediPharma Limited (Shanghai, CN) | ⤷ Try a Trial |
| Surufatinib | ⤷ Try a Trial | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | Hutchison Medipharma Limited (Shanghai, CN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Surufatinib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Surufatinib | Australia | AU2010321366 | 2029-11-23 | ⤷ Try a Trial |
| Surufatinib | Brazil | BR112012012138 | 2029-11-23 | ⤷ Try a Trial |
| Surufatinib | Canada | CA2781066 | 2029-11-23 | ⤷ Try a Trial |
| Surufatinib | China | CN102070618 | 2029-11-23 | ⤷ Try a Trial |
| Surufatinib | China | CN102648194 | 2029-11-23 | ⤷ Try a Trial |
| Surufatinib | Denmark | DK2504331 | 2029-11-23 | ⤷ Try a Trial |
| Surufatinib | European Patent Office | EP2504331 | 2029-11-23 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
